Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › South Lake Tahoe › NPI 1235727041
Lab

Test Well, LLC

Test Well, LLC was paid $52K by Medicaid between Jun 2021 and Dec 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

33Billing provider infoTEST WELL, LLC
SOUTH LAKE TAHOE, CA 96150
33aNPI1235727041assigned 01/07/2021
28Total paid$52K
24GClaims1,753
24DCodes billed3
24AFirst – last monthJun 2021 – Dec 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#361 of 561
Median peer was paid$222K
This provider vs. median0.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2021511$10K
20221,242$42K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 71% 601 492 $37K
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 22% 584 488 $11K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 7.4% 568 477 $4K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOLDWYN, CHARLES (MANAGING MEMBER)